Literature DB >> 14064022

HIGH SERUM TRANSAMINASE ACTIVITY ASSOCIATED WITH EXTRAHEPATIC BILIARY DISEASE. A CLINICAL AND PATHOLOGIC STUDY OF SIXTY PATIENTS WITH SERUM GLUTAMIC-OXALACETIC TRANSAMINASE LEVELS OF 300 UNITS OR GREATER.

S M MOSSBERG, G ROSS.   

Abstract

Entities:  

Keywords:  ASPARTATE AMINOTRANSFERASE; BILE DUCT NEOPLASMS; CHOLECYSTITIS; CHOLELITHIASIS; COMMON BILE DUCT CALCULI; CYSTIC DUCT; ENZYME TESTS; HEPATIC DUCT

Mesh：

Substances：

Year:  1963        PMID： 14064022

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  7 in total

1.  MYOCARDIAL INFARCTION-LIKE SYNDROME IN CHOLECYSTECTOMIZED PATIENTS GIVEN NARCOTICS.

Authors:  S M MOSSBERG
Journal:  Br Med J       Date:  1964-04-11

2.  Misleading SGOT (aspartate aminotransferase) values in obstructive jaundice due to pancreatic carcinoma.

Authors:  P B Gregory; D P Cooney
Journal:  Am J Dig Dis       Date:  1976-06

3.  Very high levels of SGOT and LDH in patients with extrahepatic biliary tract obstruction.

Authors:  A L Ginsberg
Journal:  Am J Dig Dis       Date:  1970-09

4.  Marked elevations of serum glutamic oxalacetic transaminase and lactic dehydrogenase activity in chronic extraheptic biliary disease.

Authors:  A Abbruzzese; R L Jeffery
Journal:  Am J Dig Dis       Date:  1969-05

5.  Prospective study of clinical and biochemical features of symptomatic choledocholithiasis.

Authors:  M L Anciaux; G Pelletier; P Attali; B Meduri; C Liguory; J P Etienne
Journal:  Dig Dis Sci       Date:  1986-05       Impact factor: 3.199

6.  Choledocholithiasis presenting with very high transaminase level.

Authors:  Amy Agahi; Alistair McNair
Journal:  BMJ Case Rep       Date:  2012-11-27

7.  Markedly Elevated Liver Enzymes in Choledocholithiasis in the absence of Hepatocellular Disease: Case Series and Literature Review.

Authors:  Eula Plana Tetangco; Natasha Shah; Hafiz Muhammad Sharjeel Arshad; Hareth Raddawi
Journal:  J Investig Med High Impact Case Rep       Date:  2016-05-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.